This article is more than 5 years old. Information may no longer be current.
Cardiology Today's top articles in June
In June 2017, Cardiology Today readers were most interested in incident HF risk for postmenopausal women, substituting polyunsaturated fats for saturated fats to lower CVD risk, diabetes drugs reducing CV risk, CAC score calculating a more accurate atherosclerotic CVD risk, the topline results from the CANTOS study and much more.
Risk for incident HF may be higher in postmenopausal women
Postmenopausal women with a shorter total reproductive period had a higher risk for incident HF, and those who had never given birth had increased risk for HF with preserved ejection fraction, according to a study in the Journal of the American College of Cardiology.
AHA: Polyunsaturated fats as substitute for saturated fats lower risk for CVD
The American Heart Association recommended substituting saturated fat with monounsaturated and polyunsaturated fats to lower cholesterol and reduce the risk for CVD, according to a presidential advisory published in Circulation.
Some diabetes drugs reduce CV risks, but clinical judgment required
PHILADELPHIA — Clinical trials support that certain glucose-lowering agents for diabetes reduce the risk for CVD. However, clinical judgment is imperative toward navigating the different agents, according to a presentation at the National Lipid Association Scientific Sessions.
CAC score helps calculate more accurate atherosclerotic CVD risk
PHILADELPHIA — Coronary artery calcium scoring leads to an improved determination of CHD and atherosclerotic CVD risk, an expert said at the National Lipid Association Scientific Sessions.
CANTOS: Canakinumab reduces risk for major CV events in patients with MI, inflammatory atherosclerosis
In patients with prior MI and inflammatory atherosclerosis, canakinumab in combination with standard-of-care therapy reduced risk for major adverse CV events, according to the topline results of the CANTOS study announced by Novartis.